Evidence that a Single Peptide–MHC Complex on a Target Cell Can Elicit a Cytolytic T Cell Response  by Sykulev, Yuri et al.
Immunity, Vol. 4, 565±571, June, 1996, Copyright 1996 by Cell Press
Evidence that a Single Peptide±MHC Complex
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Yuri Sykulev, Michael Joo, Irina Vturina, at steady state can then be estimated from the free
peptide concentration; the equilibrium constant for theTheodore J. Tsomides, and Herman N. Eisen
Center for Cancer Research peptide±MHC reaction; and the total number of accessi-
ble (functionally empty) MHC binding sites per cell. Al-and Department of Biology
Massachusetts Institute of Technology though this approach can be considered to yield only
approximate values, it suggested that the epitope densi-Cambridge, Massachusetts 02139
ties required for half-maximal cytolytic responses by
cytotoxic T lymphocytes (CTLs) varied from several
thousand pepMHC complexes per target cell to fewerSummary
than ten with different combinations of MHC proteins,
peptides, and CTLs (Kageyama et al., 1995). In addition,Using a chemically homogeneous radiolabeled pep-
two independent models for T cell±target cell interac-tide of high specific activity (125I-QLSPYPFDL, 3.5 3
tions have proposed that activation of a T cell can be1018 cpm per mole) we show that at a peptide concen-
initiated by 3±5 pepMHC complexes (Brower et al., 1994)tration (5 pM) causing half-maximal lysis of target cells
or by fewer than 10 complexes per target cell (Sykulevby a cytolytic T lymphocyte (CTL) clone that recog-
et al., 1995).nizes the peptide in association with Ld, a class I MHC
The low values are of interest because, if correct, theyprotein, only 3 peptide molecules on average are
focus attention on a critical question concerning thebound by Ld per target cell. From the distribution of
physiologic activation of T cells: whether T cell triggeringLd on the target cells, we suggest that a single peptide±
involves cross-linking TCR molecules, or whether acti-MHC complex per target cell can trigger activation of
vation occurs by perturbation of a TCR±multimolec-the T cell cytolytic response.
ular complex by a single MHC±peptide (Williams and
Beyers, 1992). Accordingly, we have sought to deter-
mine whether the low values previously suggested by
indirect approaches and reliance on models can be veri-
fied by measuring directly the number of peptide mole-Introduction
cules on antigen-presenting cells under conditions in
which these cells elicit a half-maximal cytolytic responseIn the initial antigen-specific event that leads to T cell
by CD81 T cells. For this purpose, we made use ofactivation, antigen-specific receptors on T cells (TCR)
a chemically homogeneous radioiodinated peptide ofreact with complexes formed by peptide with major his-
exceptionally high specific radioactivity. Prepared withtocompatibility complex (MHC) proteins (pepMHC com-
large amounts of carrier-free 125I and purified by highplexes) on antigen-presenting cells or target cells. As
pressure liquid chromatography (HPLC), the peptideshown in innumerable in vitro assays in which synthetic
had the same specific radioactivity as carrier-free 125Ipeptides are incubated with target cells, the intensity of
(3.5 3 1018 cpm per mole). With this peptide, we foundthe T cell response depends upon peptide concentra-
that an average of three pepMHC complexes per targettion, which, in turn, affects the density of the corre-
cell could elicit a half-maximal cytolytic T cell response.sponding pepMHC complexes (epitopes) on target cells.
This finding and the distribution of Ld on the target cellsWhile the number of these complexes per cell (epitope
suggest that the cytolytic response of some T cells maydensity) appears to be one of the critical determinants
be elicited by a target cell that bears a single pepMHCof the outcome of T cell±target cell encounters (e.g.,
complex.Ashton-Rickardt et al., 1994; Sykulev et al., 1994a;
Tsomides et al., 1994), measuring them is laborious and
only a few values have been reported. In some studies, Results
using radiolabeled peptides and immunoprecipitating
the appropriate MHC protein, the minimum epitope den- Peptide Concentration Required
for Half-Maximal Cytolysissity found to trigger antigen-specific T cell proliferation
and lymphokine production (Harding and Unanue, 1990; CTL clone 2C recognizes pepMHC complexes formed
by the class I MHC molecule Ld and one of severalDemotz et al., 1990) or a T cell cytolytic response (Chris-
tinck et al., 1991) was around 100±400 complexes per naturally processed peptides whose sequences derive
from a-ketoglutarate dehydrogenase (Udaka et al.,antigen-presenting cell.
Another approach for estimating epitope densities 1993), including p2Ca (LSPFPFDL, Udaka et al., 1992)
and QL9 (QLSPFPFDL); the latter is the most potenthas taken advantage of mutant target cells with a defect
in the peptide transporter that results in cell surface Ld-sensitizing peptide known for CTL 2C, having an SD50
value (concentration required toelicit half-maximal lysis)class I MHC molecules largely devoid of stably bound
peptides (Heemels and Ploegh, 1995). Because of this of 5 pM (Sykulev et al., 1994b), or about 100-fold less
than that of peptide p2Ca. To estimate the number ofdefect, widely different epitope densities can be estab-
lished on these cells by incubating them with synthetic Ld-bound peptide molecules per target cell required to
activate 2C cells, we first determined the free peptidepeptides at various concentrations, and the average
number of pepMHC complexes formed per target cell concentration that results in half-maximal lysis using
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cells that were incubated with GL9 the level of cell sur-
face A2 increased markedly, but the level of Ld was
unchanged. Moreover, GL9 at 1 mM, a concentration in
excess over what was required to saturate A2, did not
interfere at all with the Ld-dependent lysis of T2-Ld cells
by CTL 2C in the presence of peptide p2Ca (data not
shown). Thus, by including GL9 at 1 mM in all assays, the
binding of I1-QL9-Y5 to A2 could be prevented without
interfering with its binding to Ld.
Kinetics of I1-QL9-Y5±Ld Reaction
The rate of binding of I1-QL9-Y5 to Ld on T2-Ld cells
was examined to determine whether this peptide±MHC
reaction can approach steady-state during standard
CTL assay conditions (4 hr). Visual inspection of Figure
2A shows that the number of peptide molecules bound
specifically to T2-Ld cells reached steady-state in about
2 hr. When fit to the equation Pt 5 a(1 2 e2t/t), where Pt
is the number of peptide molecules bound specifically
per T2-Ld cell at time t, the kinetic data of Figure 2A
yielded a, the total number of Ld-bound peptide mole-Figure 1. Peptide Concentrations Required for Half-Maximal Lysis
cules per cell at steady-state at the free concentrationSpecific lysis of 51Cr-labeled T2-Ld target cells in the presence of
shown (1 3 10210 M), and also t, the time constant, i.e.,various concentrations of peptides p2Ca (LSPFPFDL), QL9
the time required to reach 63% of the steady-state value.(QLSPFPFDL), and 127I1-QL9-Y5, the monoiodinated form of QL9-Y5
(QLSPYPFDL). This time (t) was around 50 min. t becomes longer as
the peptide concentration decreases, but it cannot be
longer than the reciprocal of the rate constant of dissoci-
ation (k21) for the peptide±Ld reaction (see equation 5apeptide I1-QL9-Y5 (for sequence see Figure 1),a monoio-
in Sykulev et al., 1994a).dinated analog of QL9 available in chemically equivalent
To measure k21, we made use of an anti-Ld antibodynonradioactive (127I) and radioactive (125I) forms. As
(30-5-7) that reacts specifically with Ld if the bindingshown in Figure 1, the SD50 value of I1-QL9-Y5, was
site is occupied by peptide (Lie et al., 1990): when theabout equal to that of peptide QL9, or around 5 pM.
peptide dissociates, the resulting empty Ld molecule
undergoes rapid denaturation at 378C. Thus, by loadingSpecificity of I1-QL9-Y5 Binding to Ld on T2-Ld Cells
Ld on T2-Ld cells under conditions where brefeldin AThe T2-Ld target cells used in these studiesare of human
blocked the delivery of newly synthesized Ld to the cellorigin and express HLA-A2. Since the sequence of
surface, the time course of peptide±Ld dissociationI1-QL9-Y5 happens to fit the A2 consensus motif (it has
could be monitored by flow cytometry using antibodyleucine at positions 2 and 9), and this peptide can bind
30-5-7 (I. V. et al., unpublished data; see Experimentalto A2 as well as Ld (Table 1), it was necessary to include
Procedures). From the results shown in Figure 2B, thein the reaction mixture, along with I1-QL9-Y5 and T2-Ld
value of k21 was found to be 3.3 3 1024 sec21, yieldingcells, a peptide that could saturate the peptide-binding
an upper limit for t of about 50 min. Thus, even at thesites of A2 without occupying the peptide-binding sites
lowest peptide concentration used in this study (5of Ld. This requirement was met by the influenza virus
pM, see below), the I1-QL9-Y5±Ld reaction approachedpeptide GILGFVFTL (Bednarek et al., 1991; Morrison et
al., 1992), termed GL9. As shown in Table 1, on T2-Ld steady-state in about 1 hr.
Table 1. Peptide Binding to HLA-A2 and Ld Proteins on T2-Ld Cells Measured by Enhanced Surface Expression of These MHC Proteinsa
GILGFVFTL QLSPY(I1)PFDLPeptide
concentration (mg/ml) HLA-A2b Ld
c
HLA-A2b Ld
c
0 136.4 30 136.4 30
0.016 171 26 NDd 53.3
0.08 170 25 NDd 108
0.4 177.4 26.07 NDd 172
2.0 229 25.75 172 190
a Mean fluorescence values (linear scale) were determined after 8.5 hr incubation of T2-Ld cells with the indicated peptides at the concentrations
shown.
b Measured using mouse monoclonal antibody PA2.1 (IgG1, specific for HLA-A2) and FITC-labeled anti-mouse immunoglobulin.
c Measured using mouse monoclonal antibody 30-5-7 (IgG2a, specific for the a1 and a2 domains of Ld) and FITC-labeled anti-mouse immuno-
globulin.
d Not done.
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determined directly from the specific radioactivity of
the peptide, 3.5 3 1018 cpm/mol. At three free peptide
concentrations, 5 3 10211, 2.3 3 10211, and 5 3 10212 M,
the directly measured average epitope density values
were 50, 40, and 3 pepMHC complexes per cell, respec-
tively.
In view of the implications of these values, it is neces-
sary to consider possible sources of error. One potential
error is that 125I±peptide dissociated from Ld when the
cells were washed to remove free peptide. This possibil-
ity was ruled out by measuring the stability of the pep-
tide±Ld complexes by flow cytometry. The cells were
washed at 48C in about 10 min (see Experimental Proce-
dures), but at this temperature no dissociation could be
detected over many hours (data not shown). Another
source of error arises from cell counts: we estimate this
error to be at most 6 20%. Hence, at the lowest peptide
concentration (5 3 10212 M), the epitope density value
in this system was 3 6 1 pepMHC complexes per target
cell. With this average number, the frequencies in the
target cell population of cells having 0, 1, 2, 3, 4, and 5
pepMHC complexes per cell would be 0.05, 0.15, 0.22,
0.22, 0.17, and 0.10, respectively, assuming the Poisson
distribution to be applicable. In that event, from the sum
of these frequencies (0.91) the titration shown in Figure
1 implies that when half the target cells were lysed,
most of the lysed cells would have had fewer than five
complexes per cell and only about 10%±20% of them
would have had more than five per cell.
Is There Selective Lysis of T2-Ld Target Cells
Expressing Higher than the Average Number
of Peptide±MHC Complexes per Cell?
Alternatively, it could be argued that the distribution of
Ld molecules on T2-Ld cells is extremely asymmetric,
especially as Ld on these cells is derived from a
Figure 2. Kinetics of Binding of Monoiodinated Peptide 125I1-QL9- transfected gene. In that event, only those target cells
Y5 to Ld on T2-Ld Cells at 378C
with Ld levels much above the average might be prefer-
(A) The rate of binding of 125I1-QL9-Y5 at a free peptide concentration entially lysed. To test this possibility, we compared the
of 10210 M. The increase over time in specific binding of the peptide
distribution of Ld on the initial target cells before theyto Ld is shown by the closed circles. The solid line represents the
were introduced into a CTL assay with those that sur-best fit of the experimental points to the theoretical curve described
by thesingle exponential equation for first orderkinetics (see Results vived after 4 hr, after half had been lysed. As shown in
for details). The insert shows the change in cell-bound radioactivity Figure 3, the Ld distribution was virtually the same on
(cpm) over time in the presence (open circle) and absence (closed the initial and surviving target cells. By subtraction, it
square) of a large (10,000-fold molar) excess of the Ld-binding mouse
was clear that the lysed target cells also had a similarcytomegalovirus peptide pMCMV. The difference represents pep-
distribution.tide specifically bound to Ld.
(B) Rate of dissociation of 127I1-QL9-Y5 from Ld. Dissociation was
monitored by the loss of peptide-stabilized Ld from the surface of
brefeldin A±treated T2-Ld cells, measured by the disappearance of Discussion
FITC fluorescence from antibody-stained cells (see Experimental
Procedures). The experimental points (closed square) were fitted to With a high specific±activity radioiodinated peptide it
ln (Ft/Fo) 5 2k21 · t, where Fo and Ft are the mean fluorescence was possible to establish directly that with an averagevalues on a linear scale at time zero and time t, respectively. The
of only three pepMHC complexes per target cell, a CD81slope of a plot of ln (Ft/Fo) versus t yielded k21.
T cell clone (2C) could be stimulated to make a half-
maximal cytolytic response. Although the levels of Ld
expressed on the target cells had a broad distribution,Direct Measurement of Epitope Densities
To measure the binding of I1-QL9-Y5 directly to Ld on it was clear (Figure 3) that there was essentially no pref-
erential lysis of cells having higher than the averagetarget cells, peptide QL9-Y5 was radiolabeled with car-
rier-free 125I and incubated at 378C for 3 hr with various number of Ld molecules. Since the probability that a
peptide will bind to Ld is proportional to the total numberconcentrations with 5 3 107 T2-Ld cells in a total volume
of 5 ml. Free peptide concentrations and the numbers of Ld molecules per cell and to the number of accessible
Ld binding sites per cell, the distribution of I1-QL9-Y5±Ldof specifically bound peptide molecules per cell were
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likely that a single complex per target cell can render a
cell subject to specific lysis in the 2C system.
Of the directly measured target cell epitope densities
required to trigger T cell activity, the value reported here
is the lowest by far. Two parameters that determine
epitope density requirements are the intrinsic affinity
of the TCR±pepMHC reaction and the stability of the
TCR±pepMHC bond (bond lifetime). As was recently
suggested on the basis of the law of mass action (Syku-
lev et al., 1995), target cells with epitope densities of
1±10 pepMHC complexes per cellcan elicit half-maximal
cytolytic responses if the TCR of the CTLs bind these
complexes with an intrinsic affinity of about 106 M21 or
higher. Elsewhere, we show that the TCR on 2C cells
does indeed have such an affinity for the I1-QL9-Y5±Ld
complex (Y. S. et al., unpublished data).
How long would a single TCR±pepMHC bond have to
persist toelicit a T cell cytolytic response? We previously
found that the lifetime of the bond formed by the 2C
TCR and the QLSPFPFDL±Ld (QL9±Ld) complex is about
1 min under physiological conditions (intact T cells,
378C) (Sykulev et al., 1994b). Since peptide I1-QL9-Y5
behaves very similarly to the QL9 peptide (i.e., it also
sensitizes target cells for half-maximal lysis at 5 pM
[Figure 1] and the I1-QL9-Y5±Ld complex is bound by
the 2C TCR with high intrinsic affinity), it is likely that
under physiological conditions the lifetime of the 2C
TCR-I1-QL9-Y5±Ld bond is also around 1 min. For other
systems, having lower intrinsic TCR affinities and form-
ing shorter-lived TCR±pepMHC bonds, higher epitope
densities and a larger number of bonds are probably
required.
How can the present findings be reconciled with many
previous studies suggesting that T cell activation re-
quires multivalent ligands to bring about aggregation or
cross-linking of TCR molecules on the T cell surface
(e.g., Symer et al., 1992)? In considering the apparentFigure 3. Distribution of Ld and I1-QL9-Y5±Ld Complexes on T2-Ld
Target Cells disparity between these findings and ours, we note,
Percent of the target cells with different levels of Ld expression is first, that the term ªactivationº covers a multitude of
shown for the target cell populations that were incubated for 4 hr responses. Some are rapid (minutes to hours) and do
at 378C without the CTL and peptide (the initial population) or with not require transcription of silent genes, while others
the CTL and the peptide at 5 pM (the survived population). The Ld are slow (requiring a day or more) and depend upon
distribution on the lysed cells was determined by difference (see
activation of gene expression. The cytolytic responseExperimental Procedures). To determine whether the distribution
is relatively fast (typical assay conditions are 4 hr) andshown (top) changed over 4 hr, target cells expressing low or high
Ld levels were sorted, incubated at 378C for 4 hr, and examined is unaffected by treating the T cells with inhibitors of
again (with and without restaining) by flow cytometry. No change transcription or protein synthesis (e.g., Zychlinsky et al.,
in distribution in either subset was seen (data not shown). 1991). That it differs from slow responses such as cell
proliferation or cytokine production is evident in split
anergy, whereby an antigen-presenting cell lacking co-
complexes on the target cells should match the Ld distri- stimulatory components was found to render a CD81
bution shown in Figure 3, with the average number of cytolytic T cell clone partially anergic, i.e., the T cells
three cognate pepMHC complexes per cell correspond- retained their ability to lyse target cells but proved un-
ing to the position of the weighted average for total Ld able subsequently to proliferate (a slow response) in the
(ninth subset) in this figure. The number of complexes response to an effective antigen-presenting cell (Otten
on the lysed cells would thus extend from a low of 1 and Germain, 1991). Studies in this laboratory have also
per cell (Figure 3, third subset at the extreme left) to a shown that CTLs can be stimulated under conditions
high of about 8 (at the extreme right). As seen in the in which their cytolytic function is preserved but their
bottom panel of Figure 3, 67% of the lysed target cells proliferative activity is depressed (Dutz et al., 1992).
had three or more pepMHC complexes per cell, but 33% A single reactive pepMHC on a target cell amounts
of the lysed cells had fewer than three and 12% had to a monovalent ligand. In accord with our evidence that
only 1±2 complexes per cell. Given this extremely low such a ligand might trigger a T cell cytolytic response,
number and the likelihood that pepMHC complexes are it hasbeen reported that an increase inT cell intracellular
Ca21 concentration, an extremely rapid response, canrandomly distributed over the target cell surface, it is
A Response to One pepMHC Complex per Target Cell
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form of peptide QLSPYPFDL, termed 127I1-QL9-Y5, was preparedbe elicited almost as well by the Fab fragment of an
in the same way, using t-Boc-protected monoiodinated tyrosineanti-CD3 antibody as by the intact bivalent antibody
(Peninsula, Incorporated, Belmont, California). Because theN-termi-(Oettgen et al., 1985). It has also been shown that mono-
nal glutamine rearranges to cyclized pyrrolidone carboxylate, the
valent Fab fragments from the same anti-CD3 antibody peptide exists in two forms (separable by HPLC). Both were recog-
were able to stimulate interleukin-2 (IL-2) secretion by nized by 2C cells in association with Ld. The preparations used here
were predominantly in cyclized form. All peptide concentrationsboth syngeneic and allogeneic MHC class II±restricted
were measured by quantitative amino acid analyses.T cell clones (Tamura and Nariuchi, 1992). Whether a
single pepMHC on a target cell can be demonstrated
Stoichiometric Iodination of Peptide QLSPYPFDLdirectly to elicit such slow responses is not clear. From
(QL9-Y5) with 125I
the Brower et al. (1994) model, it was deduced that 3±5 The monoiodinated radioactive form of peptide QL9-Y5 was pre-
pepMHC complexes could stimulate a T cell to produce pared by iodination with carrier-free Na125I (Du Pont NEN) as de-
interferon-g. However, in that model, class I MHC was scribed (Tsomides and Eisen, 1993; Schumacher and Tsomides,
1995). In brief, in a typical reaction, 200 mg of purified peptide QL9-adsorbed on plastic to which relatively long peptides
Y5 was reacted with 30 mCi Na125I using two Iodo-Beads (Pierce)were added (10±15 aa in length); whether cytokine pro-
for 30 min at pH 6.0. After unbound iodide was removed from theduction can be elicited by a similar number of pepMHC
peptide mixture using a Sep-Pak C18 cartridge (Waters) in a glove
in a more physiological setting remains to be seen. box, the labeled peptide products and unreacted QL9-Y5 were re-
Although antigen-induced cross-linking and oligo- solved from one another on a 4.6 3 250 mm reverse phase C18
merization of TCR molecules on the T cell surface are HPLC column (Vydac) with a 1%/min acetonitrile gradient, using on-
line radioisotope detection (Beckman model 170). Individual radiola-often considered as though they are the same, a distinc-
beled products were dried, resuspended in H2O, and aliquots weretion between them emerges from the evidence that a
counted in a g counter (Packard) with a known counting efficiencysingle pepMHC complex on a target cell can stimulate
of 75% to determine the specific radioactivities of the peptides. The
a T cell. While a single complex, acting as a monovalent specific radioactivity of monoiodinated 125I1-QL9-Y5 was the same
ligand, cannot literally cross-link T cell receptors, it as that of carrier-free 125I (3.5 3 1018 cpm/mol). The composition of
could conceivably bring about their oligomerization. this peptide was further confirmed by Edman degradation after
HPLC purification (Tsomides and Eisen, 1993).That TCR molecules have a propensity to form dimers
is suggested by the recent crystallographic study by
AntibodiesFields et al. (1995), and it can be imagined that monova-
Mouse monoclonal antibodies PA2.1 (IgG1, anti-HLA-A2; Brodsky
lent pepMHC ligation of a TCR could enhance this ten- et al., 1979) and 30-5-7 (IgG2a, anti-Ld; Ozato et al., 1980; Lie et al.,
dency, perhaps by inducing a conformational change in 1990) were isolated from supernatants of hybridoma cell cultures
the TCR (e.g., Rojo and Janeway, 1988). In an analogous using protein A affinity chromatography.
situation, conformational changes of immunoglobulin
Cytolytic Assayresulting from antigen binding have been demonstrated
Peptides (50 ml) at various concentrations in phosphate-buffered(e.g., Stanfield et al., 1993).
saline (PBS) were added to 5 3 103 51Cr-labeled target cells (T2-Ld)While a single pepMHC can react with only a single
and 1.5±2.5 3 104 CTL (2C) in 150 ml of K medium in round-bottomed
TCR at any instant, over time it can engage many of wells of microtiter plates. After brief centrifugation (300 3 g for 5
them, reacting repetitively with the same TCR molecule min), the plates were incubated in a CO2 incubator for 4 hr at 378C.
or serially with many different TCR molecules as recently Percent specific lysis was calculated from the average of duplicates
as 100 3 ([51Cr experimentally released 2 spontaneous release] /emphasized by Valitutti et al. (1995). The number of
[total release in 0.1% NP40 2 spontaneous release]).engagements associated with a given T cell response
depends, in part, on the lifetime of the TCR±pepMHC
Flow Cytometry
bond. The few dissociation rate constants reported so To measure peptide-dependent stabilization of A2 and Ld molecules
far indicate that the lifetimes of these bonds range from on T2-Ld cells, the cells were incubated with various peptide concen-
about 1±100 s (Sykulev et al., 1994a, 1994b; Matsui et trations at 378C for 6±12 hr. Expression of cell surface A2 and Ld
was detected with antibodies PA2.1 and 30-5-7, respectively, fol-al., 1994; Corr et al., 1994), but how long the bonds have
lowed by staining the cell-bound antibodies with fluorescein isothio-to persist in order to elicit particular responses remains
cyanate (FITC)±labeled F(ab9)2 fragments of goat antibodies toto be determined.
mouse immunoglobulins. The levels of expression of the MHC pro-
teins were measured by mean fluorescence on a linear scale.
Experimental Procedures
Kinetic Analysis of the Reaction Between I1-QL9-Y5
Cells and Ld on T2-Ld Cells
The CD81 cytolytic T cell clone 2C was maintained as described Sixteen tubes, each containing 5 3 107 cells in 5 ml K medium, were
(Kranz et al., 1984). The human hybridoma T2 transfected with the incubated with influenza virus matrix peptide GL9 at 1±2 mM for 1
Ld gene (Alexander et al., 1989) was cultured in K medium (RPMI hr at 378C. I1-QL9-Y5 was then introduced into all tubes at 10210 M.
1640 supplemented with 10% heat-inactivated fetal calf serum, 10 To correct for nonspecific binding of the 125I±peptide to the cells,
mM HEPES, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml peptide YPHFMPTNL (pMCMV, Reddehase et al., 1989) was added
streptomycin, 50 mM b-mercaptoethanol) in the presence of 320 mg/ to half the tubes at a final concentration of 1±2 3 1026 M; this
ml G418. concentration greatly exceeds what is required to saturate the Ld
binding sites, since the equilibrium binding constant for the
pMCMV±Ld reaction is about 2 3 109 M21 (Sykulev et al., 1994a).Peptides
Except for the influenza virus matrix peptide GILGFVFTL, which The tubes were slowly rotated on a stirring wheel at 378C and after
each hour duplicate tubes containing the labeled peptide only (towas provided by Drs. M. Bouvier and D. Wiley (Harvard University,
Cambridge,Massachusetts) (Bouvier and Wiley, 1994), all other pep- measure total binding) and duplicate tubes containing both the la-
beled peptide and the Ld-blocking unlabeled peptide were centri-tides were synthesized by solid phase t-Boc chemistry in the Massa-
chusetts Institute of Technology Biopolymers Laboratory and puri- fuged at 48C. After removing supernatants, which were counted to
measure the free concentration of 125I±peptide, the cell pellets werefied by reverse phase HPLC. The monoiodinated nonradioactive
Immunity
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washed twice with ice-cold K medium, resuspended in 2±3 ml of The levels of Ld onthe intitial andsurviving T2-Ld target cell popula-
tions (PKH261PI2) were compared by flow cytometry by measuringice-cold K medium, and layered on 2 ml of silicone-paraffin oil mix-
ture (see above) and centrifuged at 48C. After freezing the centrifuge FITC fluorescence intensity of the antibody-stained cells on a linear
scale. The fluorescence of these cells fell within channels 20 andtubes, the tips were cut off to measure cell-bound 125I±peptide. Dis-
sociation of the labeled cell-bound peptide during manipulations at 520, and this region was divided into 25 equal intervals. Numbered
from 1±25, the intervals provided a relative measure of the cell48C was shown to be negligible (I. V. et al., unpublished data).
To determine the rate constant of dissociation (k21) of I1-QL9-Y5 surface level of Ld. The distributions of Ld on both the intitial and
surviving target cell populations were displayed by plotting the per-from Ld, 5 3 105 T2-Ld cells were preincubated in a total volume of
200 ml with 5 mM brefeldin A for 40 min at 378C to block delivery of cent of all PKH261PI2FITC1 cells for a given population in each of
the numbered (n) intervals. To determine the Ld distribution on thenewly produced MHC molecules to the cell surface. Peptide 127I1-
QL9-Y5 was then added at a final concentration of 4 3 1024 M and lysed target cells, we calculated the percent of lysed cells in each
interval (Pkn ) from:incubation was continued at 378C. After the cell suspension was
subjected to rapid centrifugation, the supernatant was promptly
removed and the cells were washed twice with ice-cold K medium
Pkn 5
Pintn 2 (1 2 fk ) Psn
fkand resuspended in K medium that was preheated to 378C and
contained 5 mM brefeldin A. An aliquot of the cell suspension was
taken immediately (time zero) and placed on ice. The remaining cells where Pintn and Psn are the percentages of initial and survived target
were kept at 378C and samples were removed every 15±20 min, cells, respectively, in the nth interval, and fk is the fraction of specifi-
placed on ice, and stained with 30-5-7 anti-Ld antibody as described cally lysed cells determined from released 51Cr. Values of Pkn were
above, to determine their mean Ld expression by flow cytometry. plotted as a function of the interval number n. Relative weighted
The results were analysed as described in the legend to Figure 2. average values (means) of Ld expression (nÅ ) in all three populations
of target cells (initial, survived, and lysed) were calculated as:
Direct Measurement of I1-QL9-Y5±Ld Complexes
on T2-Ld Cells
The number of I1-QL9-Y5±Ld complexes on T2-Ld cells was measured n 5
S
25
n51
Pn·n
100directly with cells that were incubated at 378C for 3 hr (Figure 2, see
equilibrium time) with 125I1-QL9-Y5 at three different concentrations:
5 3 10211, 2.3 3 10211, and 5 3 10212 M. We added peptide 125I1- Acknowledgments
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